SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?


To: Snowshoe who wrote (155986)4/5/2020 4:38:12 AM
From: TobagoJack2 Recommendations

Recommended By
Dr. Voodoo
marcher

  Read Replies (1) | Respond to of 219173
 
Re <<Depression tactics...>>

last nation standing tactics

just out a few minutes ago

bloomberg.com

India Bans All Exports of Trump’s ‘Game Changer’ Virus Drug

Rajesh Kumar Singh
5 April 2020, 09:42 GMT+2



A pack of Hydroxychloroquine Sulfate medication.

Photographer: John Phillips/Getty Images

LISTEN TO ARTICLE
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.

India put a total ban on exports of hydroxychloroquine, a malaria drug that U.S. President Donald Trump has touted as a “ game changer” in the fight against Covid-19.

Exports of the drug and its formulations have been prohibited “without any exceptions” and with immediate effect, India’s Directorate General of Foreign Trade said in an April 4 order on its website. The trade regulator had last month restricted overseas shipments of the drug, allowing only limited exceptions such as on humanitarian grounds and for meeting prior commitments.

The new ban reflects India’s rising concern over the rapid spread of the novel coronavirus, with incidents of community spread emerging from different parts of the country of 1.3 billion people.

It comes on a weekend when Prime Minister Narendra Modi discussed the global supply chain for drugs and other medical supplies with Trump, who has advocated the use of hydroxychloroquine as a potential treatment for people with Covid-19. Its efficacy against coronavirus infections remains unproven.

India has recorded 3,374 positive cases so far and has lost 77 lives, according to the federal health ministry. The country has struggled to keep people indoors during a three-week lockdown that started March 25, raising fears of accelerating spread.

Before it's here, it's on the Bloomberg Terminal.
LEARN MORE